A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters

The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to dramatic economic and health burdens. Although the worldwide SARS-CoV-2 vaccination campaign has begun, exploration of other vaccine candidates is needed due...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Mijia, Zhang, Yuexiu, Dravid, Piyush, Li, Anzhong, Zeng, Cong, KC, Mahesh, Trivedi, Sheetal, Sharma, Himanshu, Chaiwatpongsakorn, Supranee, Zani, Ashley, Kenney, Adam, Cai, Chuanxi, Ye, Chengjin, Liang, Xueya, Qiu, Jianming, Martinez-Sobrido, Luis, Yount, Jacob S., Boyaka, Prosper N., Liu, Shan-Lu, Peeples, Mark E., Kapoor, Amit, Li, Jianrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475528/
https://www.ncbi.nlm.nih.gov/pubmed/34379509
http://dx.doi.org/10.1128/JVI.00592-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475528/
https://www.ncbi.nlm.nih.gov/pubmed/34379509
http://dx.doi.org/10.1128/JVI.00592-21

Ejemplares similares